Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transsexualism | 11 | 2022 | 206 | 4.480 |
Why?
|
| 5-alpha Reductase Inhibitors | 8 | 2020 | 117 | 3.630 |
Why?
|
| Finasteride | 8 | 2022 | 90 | 3.520 |
Why?
|
| Testosterone | 18 | 2024 | 2471 | 3.060 |
Why?
|
| Hormone Replacement Therapy | 7 | 2021 | 754 | 2.130 |
Why?
|
| Sex Reassignment Procedures | 4 | 2024 | 70 | 1.850 |
Why?
|
| Sexual Dysfunction, Physiological | 6 | 2022 | 357 | 1.800 |
Why?
|
| Alopecia | 5 | 2020 | 414 | 1.730 |
Why?
|
| Hypogonadism | 5 | 2021 | 800 | 1.300 |
Why?
|
| Voice | 2 | 2017 | 268 | 0.890 |
Why?
|
| Estrogens | 3 | 2022 | 1520 | 0.870 |
Why?
|
| Erectile Dysfunction | 2 | 2020 | 451 | 0.820 |
Why?
|
| Sexual Dysfunctions, Psychological | 2 | 2014 | 189 | 0.770 |
Why?
|
| Genital Diseases, Male | 1 | 2021 | 83 | 0.760 |
Why?
|
| Orchiectomy | 2 | 2014 | 470 | 0.730 |
Why?
|
| Hypertriglyceridemia | 1 | 2022 | 293 | 0.670 |
Why?
|
| Off-Label Use | 1 | 2020 | 185 | 0.610 |
Why?
|
| Hyperlipidemias | 1 | 2022 | 772 | 0.590 |
Why?
|
| Ambulatory Care Facilities | 1 | 2022 | 927 | 0.530 |
Why?
|
| Blood Pressure | 5 | 2022 | 8451 | 0.520 |
Why?
|
| Penile Erection | 1 | 2015 | 100 | 0.500 |
Why?
|
| Policy | 1 | 2018 | 511 | 0.480 |
Why?
|
| Osteoporosis | 2 | 2014 | 1598 | 0.470 |
Why?
|
| Eunuchism | 1 | 2014 | 19 | 0.470 |
Why?
|
| Dihydrotestosterone | 1 | 2014 | 195 | 0.460 |
Why?
|
| Gender Identity | 5 | 2022 | 757 | 0.450 |
Why?
|
| Conflict of Interest | 1 | 2018 | 548 | 0.450 |
Why?
|
| Klinefelter Syndrome | 1 | 2013 | 47 | 0.450 |
Why?
|
| Prothrombin | 1 | 2013 | 190 | 0.430 |
Why?
|
| Drinking Behavior | 1 | 2013 | 103 | 0.420 |
Why?
|
| Hyperprolactinemia | 1 | 2013 | 123 | 0.400 |
Why?
|
| Self Mutilation | 1 | 2012 | 58 | 0.390 |
Why?
|
| Weight Gain | 1 | 2021 | 2346 | 0.370 |
Why?
|
| Prolactin | 1 | 2013 | 621 | 0.370 |
Why?
|
| Testis | 1 | 2014 | 794 | 0.360 |
Why?
|
| Spermatozoa | 1 | 2014 | 631 | 0.360 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2020 | 1079 | 0.350 |
Why?
|
| Hashimoto Disease | 1 | 2010 | 105 | 0.320 |
Why?
|
| Male | 42 | 2024 | 358747 | 0.310 |
Why?
|
| Suicide | 1 | 2020 | 1599 | 0.310 |
Why?
|
| Sjogren's Syndrome | 1 | 2010 | 235 | 0.310 |
Why?
|
| Self-Injurious Behavior | 1 | 2014 | 556 | 0.290 |
Why?
|
| Obesity | 3 | 2021 | 12870 | 0.280 |
Why?
|
| Androgens | 1 | 2014 | 1291 | 0.280 |
Why?
|
| Self Care | 1 | 2012 | 794 | 0.270 |
Why?
|
| Sexual Behavior | 2 | 2018 | 2158 | 0.270 |
Why?
|
| Humans | 49 | 2024 | 758406 | 0.250 |
Why?
|
| Adult | 27 | 2024 | 219935 | 0.250 |
Why?
|
| Bone Density | 3 | 2018 | 3533 | 0.240 |
Why?
|
| District of Columbia | 2 | 2021 | 160 | 0.230 |
Why?
|
| Longitudinal Studies | 4 | 2022 | 14490 | 0.220 |
Why?
|
| Bone and Bones | 1 | 2013 | 2560 | 0.210 |
Why?
|
| Cholesterol, LDL | 1 | 2012 | 2374 | 0.210 |
Why?
|
| Triglycerides | 2 | 2022 | 2451 | 0.200 |
Why?
|
| Gonadotropin-Releasing Hormone | 2 | 2006 | 1153 | 0.200 |
Why?
|
| Suicidal Ideation | 1 | 2012 | 1430 | 0.200 |
Why?
|
| Patient Education as Topic | 1 | 2012 | 2307 | 0.200 |
Why?
|
| Hypertension | 1 | 2022 | 8499 | 0.200 |
Why?
|
| Thyroxine | 2 | 2020 | 667 | 0.200 |
Why?
|
| Endocrinology | 2 | 2018 | 441 | 0.200 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2016 | 3992 | 0.190 |
Why?
|
| Product Surveillance, Postmarketing | 2 | 2020 | 451 | 0.190 |
Why?
|
| Hormones | 2 | 2022 | 869 | 0.190 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7378 | 0.190 |
Why?
|
| beta Carotene | 1 | 2002 | 523 | 0.190 |
Why?
|
| Fruit | 2 | 2005 | 1160 | 0.180 |
Why?
|
| Aspirin | 1 | 2012 | 3131 | 0.180 |
Why?
|
| Adolescent | 12 | 2022 | 87892 | 0.180 |
Why?
|
| Depressive Disorder | 1 | 2012 | 3727 | 0.170 |
Why?
|
| Female | 22 | 2024 | 390323 | 0.160 |
Why?
|
| Young Adult | 9 | 2021 | 58808 | 0.160 |
Why?
|
| Health Care Costs | 1 | 2012 | 3245 | 0.160 |
Why?
|
| Triiodothyronine | 1 | 2020 | 493 | 0.150 |
Why?
|
| Semen Analysis | 1 | 2020 | 234 | 0.150 |
Why?
|
| Growth Hormone | 1 | 2020 | 568 | 0.150 |
Why?
|
| Speech Production Measurement | 1 | 2017 | 96 | 0.150 |
Why?
|
| Lipid Metabolism Disorders | 1 | 2017 | 20 | 0.140 |
Why?
|
| Thyroid Hormones | 1 | 2020 | 403 | 0.140 |
Why?
|
| Estradiol | 1 | 2024 | 1933 | 0.140 |
Why?
|
| Reference Values | 2 | 2021 | 4919 | 0.140 |
Why?
|
| Speech Acoustics | 1 | 2017 | 154 | 0.140 |
Why?
|
| Thyrotropin | 1 | 2020 | 832 | 0.130 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2020 | 488 | 0.130 |
Why?
|
| Cholesterol, HDL | 1 | 2022 | 1808 | 0.130 |
Why?
|
| Sperm Count | 2 | 2014 | 228 | 0.130 |
Why?
|
| Exercise | 1 | 2012 | 5788 | 0.130 |
Why?
|
| Bipolar Disorder | 1 | 2013 | 5079 | 0.130 |
Why?
|
| Depression | 1 | 2015 | 8057 | 0.130 |
Why?
|
| Breast | 1 | 2024 | 1963 | 0.120 |
Why?
|
| Syndrome | 1 | 2021 | 3262 | 0.120 |
Why?
|
| Libido | 1 | 2015 | 119 | 0.120 |
Why?
|
| Osteocalcin | 1 | 2014 | 274 | 0.110 |
Why?
|
| Thalassemia | 1 | 2014 | 270 | 0.110 |
Why?
|
| Costa Rica | 3 | 2005 | 177 | 0.110 |
Why?
|
| Men's Health | 1 | 2013 | 73 | 0.110 |
Why?
|
| Sperm Motility | 1 | 2014 | 265 | 0.110 |
Why?
|
| Mammography | 1 | 2024 | 2427 | 0.110 |
Why?
|
| Disclosure | 1 | 2018 | 738 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2017 | 12075 | 0.100 |
Why?
|
| Central Nervous System Depressants | 1 | 2013 | 164 | 0.100 |
Why?
|
| Alopecia Areata | 1 | 2014 | 127 | 0.100 |
Why?
|
| United States | 7 | 2018 | 72136 | 0.100 |
Why?
|
| Self Concept | 1 | 2017 | 1041 | 0.100 |
Why?
|
| Psychiatric Department, Hospital | 1 | 2012 | 126 | 0.100 |
Why?
|
| Administration, Cutaneous | 1 | 2013 | 712 | 0.100 |
Why?
|
| Hemoglobins | 1 | 2017 | 1519 | 0.090 |
Why?
|
| Cardiovascular System | 1 | 2018 | 835 | 0.090 |
Why?
|
| Proteins | 2 | 2006 | 6026 | 0.090 |
Why?
|
| Lipids | 2 | 2006 | 3326 | 0.090 |
Why?
|
| Internet | 1 | 2022 | 3082 | 0.090 |
Why?
|
| Sialadenitis | 1 | 2010 | 45 | 0.090 |
Why?
|
| Bone Resorption | 1 | 2013 | 720 | 0.090 |
Why?
|
| Teaching | 1 | 1997 | 1168 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2005 | 12759 | 0.080 |
Why?
|
| Societies, Medical | 2 | 2018 | 3891 | 0.080 |
Why?
|
| Neurotransmitter Agents | 1 | 2013 | 663 | 0.080 |
Why?
|
| Debridement | 1 | 2012 | 492 | 0.080 |
Why?
|
| Mutation | 1 | 2013 | 29915 | 0.080 |
Why?
|
| Diphosphonates | 1 | 2013 | 636 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2020 | 22029 | 0.080 |
Why?
|
| Single-Blind Method | 1 | 2012 | 1570 | 0.080 |
Why?
|
| Education, Medical, Undergraduate | 1 | 1997 | 1066 | 0.080 |
Why?
|
| Middle Aged | 11 | 2024 | 219568 | 0.080 |
Why?
|
| Diet | 2 | 2005 | 8005 | 0.080 |
Why?
|
| Postoperative Hemorrhage | 1 | 2012 | 413 | 0.080 |
Why?
|
| Imidazoles | 1 | 2013 | 1179 | 0.070 |
Why?
|
| Body Mass Index | 2 | 2024 | 12876 | 0.070 |
Why?
|
| Self Report | 1 | 2018 | 3714 | 0.070 |
Why?
|
| Contraceptive Agents, Male | 1 | 2006 | 8 | 0.070 |
Why?
|
| Ethanol | 1 | 2013 | 1323 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2017 | 54137 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 11892 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2012 | 9267 | 0.070 |
Why?
|
| Injections, Subcutaneous | 2 | 2024 | 677 | 0.070 |
Why?
|
| Treatment Outcome | 4 | 2017 | 64378 | 0.070 |
Why?
|
| Cost Savings | 1 | 2012 | 918 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2024 | 10748 | 0.060 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2006 | 155 | 0.060 |
Why?
|
| Neurons | 1 | 2005 | 9416 | 0.060 |
Why?
|
| Oncogene Proteins v-fos | 1 | 2005 | 16 | 0.060 |
Why?
|
| Castration | 1 | 2005 | 153 | 0.060 |
Why?
|
| Vitamin D Deficiency | 1 | 2014 | 1377 | 0.060 |
Why?
|
| Injections, Intraventricular | 1 | 2005 | 225 | 0.060 |
Why?
|
| Androgen Antagonists | 1 | 2013 | 1442 | 0.060 |
Why?
|
| Immunologic Factors | 1 | 2013 | 1585 | 0.060 |
Why?
|
| Urban Population | 1 | 2012 | 2025 | 0.060 |
Why?
|
| Receptors, Neuropeptide | 1 | 2005 | 105 | 0.060 |
Why?
|
| Radioimmunoassay | 1 | 2005 | 866 | 0.060 |
Why?
|
| Patient Admission | 1 | 2012 | 1372 | 0.060 |
Why?
|
| Aged | 5 | 2020 | 168218 | 0.060 |
Why?
|
| Cardiovascular Diseases | 2 | 2018 | 15399 | 0.060 |
Why?
|
| Tocopherols | 1 | 2002 | 44 | 0.050 |
Why?
|
| Xanthophylls | 1 | 2002 | 94 | 0.050 |
Why?
|
| Injections, Intramuscular | 1 | 2024 | 553 | 0.050 |
Why?
|
| Motivation | 1 | 2012 | 1996 | 0.050 |
Why?
|
| Cholesterol | 2 | 2002 | 2902 | 0.050 |
Why?
|
| Lutein | 1 | 2002 | 122 | 0.050 |
Why?
|
| Luteinizing Hormone | 1 | 2005 | 820 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2015 | 3586 | 0.050 |
Why?
|
| Diet Surveys | 2 | 2005 | 1161 | 0.050 |
Why?
|
| Micronutrients | 1 | 2005 | 381 | 0.050 |
Why?
|
| Disease Management | 1 | 2012 | 2500 | 0.050 |
Why?
|
| Risk Factors | 3 | 2017 | 73809 | 0.050 |
Why?
|
| Myocardial Infarction | 2 | 2018 | 11424 | 0.050 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 1900 | 0.050 |
Why?
|
| Anticarcinogenic Agents | 1 | 2002 | 249 | 0.050 |
Why?
|
| Vitamin D | 1 | 2014 | 3283 | 0.050 |
Why?
|
| Cell Count | 1 | 2005 | 1835 | 0.050 |
Why?
|
| Isotretinoin | 1 | 2022 | 132 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2013 | 4018 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2005 | 1414 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2020 | 6803 | 0.040 |
Why?
|
| Thrombosis | 1 | 2013 | 2929 | 0.040 |
Why?
|
| Vegetables | 1 | 2005 | 1195 | 0.040 |
Why?
|
| Carotenoids | 1 | 2002 | 620 | 0.040 |
Why?
|
| Nutrition Assessment | 1 | 2002 | 726 | 0.040 |
Why?
|
| Oligopeptides | 1 | 2005 | 1185 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 2850 | 0.040 |
Why?
|
| Aging | 1 | 2018 | 8650 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2014 | 3765 | 0.040 |
Why?
|
| Medicaid | 1 | 2012 | 2807 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2013 | 4777 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2005 | 1245 | 0.040 |
Why?
|
| Antioxidants | 1 | 2005 | 1662 | 0.040 |
Why?
|
| Teaching Rounds | 1 | 2021 | 275 | 0.030 |
Why?
|
| Infertility, Male | 1 | 2020 | 396 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 10146 | 0.030 |
Why?
|
| Anthropometry | 1 | 2000 | 1347 | 0.030 |
Why?
|
| Incidence | 1 | 2014 | 21272 | 0.030 |
Why?
|
| Lipoproteins | 1 | 2000 | 881 | 0.030 |
Why?
|
| Demography | 1 | 2000 | 1651 | 0.030 |
Why?
|
| Prevalence | 1 | 2012 | 15651 | 0.030 |
Why?
|
| Time Factors | 1 | 2016 | 39872 | 0.030 |
Why?
|
| Family Practice | 1 | 1997 | 510 | 0.030 |
Why?
|
| Feeding Behavior | 2 | 2005 | 3184 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2005 | 8143 | 0.030 |
Why?
|
| Fertility | 1 | 2018 | 773 | 0.030 |
Why?
|
| Peptides | 1 | 2005 | 4341 | 0.030 |
Why?
|
| Child | 4 | 2022 | 79818 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 7810 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2013 | 23884 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 11070 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 20500 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2022 | 2889 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2012 | 15637 | 0.020 |
Why?
|
| Faculty, Medical | 1 | 1997 | 1192 | 0.020 |
Why?
|
| Animals | 2 | 2015 | 167768 | 0.020 |
Why?
|
| Rats | 1 | 2005 | 23679 | 0.020 |
Why?
|
| HIV Infections | 1 | 2014 | 17275 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2018 | 2621 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2000 | 7818 | 0.020 |
Why?
|
| Sex Factors | 1 | 2000 | 10504 | 0.020 |
Why?
|
| Drug Administration Routes | 1 | 2006 | 150 | 0.020 |
Why?
|
| Gonadotropins | 1 | 2006 | 241 | 0.020 |
Why?
|
| Spermatogenesis | 1 | 2006 | 257 | 0.020 |
Why?
|
| Gels | 1 | 2006 | 419 | 0.020 |
Why?
|
| Adolescent Nutritional Physiological Phenomena | 1 | 2005 | 62 | 0.020 |
Why?
|
| Mass Screening | 1 | 2021 | 5427 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2006 | 697 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2018 | 3941 | 0.010 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2006 | 546 | 0.010 |
Why?
|
| Smoking | 1 | 2000 | 9051 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 1539 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2021 | 26183 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2006 | 2020 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2000 | 25956 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2024 | 21017 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2005 | 1607 | 0.010 |
Why?
|
| Body Weight | 1 | 2006 | 4603 | 0.010 |
Why?
|
| Health Status | 1 | 2005 | 4071 | 0.010 |
Why?
|
| Insulin | 1 | 2006 | 6578 | 0.010 |
Why?
|
| Age Factors | 1 | 2005 | 18358 | 0.000 |
Why?
|
Concepts
(232)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_